Propofol and/or etomidate-induced immune thrombocytopenia: A case report.

Key Points

• The objective is to report on the occurrence of immune-mediated thrombocytopenia associated with propofol and/or etomidate use in anesthesia.
• Case report detailing a specific instance of thrombocytopenia following anesthesia with propofol and/or etomidate.
• Discussion of clinical observations and differential diagnoses considered by anesthesiologists.
• Identification of immune-mediated thrombocytopenia as a rare but significant reaction to propofol and/or etomidate.
• Emphasis on the need for awareness among anesthesiologists about this possible adverse reaction.